Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Withdrawal of Albumin (Human) 5 %-Talecris Biotherapeutics


April 30, 2008


Plasbumin-5     Albumin (Human) 5%, USP

Lot Number: 26N9P21
Expiration Date: March 7, 2011


Talecris Biotherapeutics Clayton, North Carolina


Talecris Biotherapeutics is initiating a Voluntary Withdrawal of one lot of Plasbumin-5, Albumin (Human) 5%, USP. The lot is being withdrawn due to internal audit findings at the plasma collection facility that provided the Source Plasma used to produce this product lot. These findings indicate inadequate documentation of storage and handling prior to shipment of the plasma to the Talecris manufacturing facility. No adverse events or product complaints have been reported or associated with the use of this lot.

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 06/27/2013
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English